DEFINITIVE PROXY STATEMENT

Company

Theriva Biologics, Inc.

Filed

January 4, 2012

Period of Report

February 15, 2012

Accession Number

0001144204-12-000314

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →